Eye symptoms can signal underlying kidney disease. Learn about shared causes, early warning signs, and prevention tips to protect your vision and maintain kidney health.

The global diabetic nephropathy market revenue was around US$ 2.0 billion in 2022 and is estimated to reach US$ 3.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 6% during the ...

However, here’s the tricky part: as people get older, kidney function naturally slows down. This means a lower GFR might not always be a sign of disease—it could just be a part of aging. This makes it ...

Type 2 diabetes isn’t just a condition, it’s a long-term health risk that evolves silently. Timely testing, accurate readings ...

China: A recent retrospective cohort study published in Diabetes, Metabolic Syndrome and Obesity has revealed a significant U ...

Morphic Therapeutic Inc. has identified compounds acting as integrin αvβ1 antagonists reported to be useful for the treatment of cancer, chronic kidney disease, diabetic nephropathy, pulmonary ...

The diabetic nephropathy market is driven by the growing burden of diabetes and the increasing demand for effective treatments for kidney disease. Advances in therapeutics, including new drug classes ...

gCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Madrid, Spain Although the prevalence of all stages of diabetic retinopathy ...

Post hoc results support the initiation of SGLT2 inhibitors in patients with diabetic nephropathy regardless of iron deficiency. Canagliflozin treatment may improve iron markers and hemoglobin levels ...

Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. has synthesized cytochrome P450 11B2, mitochondrial (CYP11B2; aldosterone synthase; ALDOS) inhibitors reported to be useful for the ...

Medically reviewed by Matthew Wosnitzer, MD Foamy pee may be a sign of proteinuria, a condition in which protein ...

A new study published in the journal of Frontiers in Endocrinology showed that patients with type 2 diabetes mellitus who have steatotic liver disease (SLD) are more likely to experience ...